Key result
The Summary Hospital-level Mortality Indicator for MI fell from 96 to 65.4 when restricted to only type 1 MI, demonstrating that inclusion of type 2 or non-MI can cause inaccuracies.
Why the study?
The study aimed to assess the accuracy of MI as a diagnosis in the SHMI for MI and evaluate the healthcare received by patients with type 1 MI included in this indicator.
Observational (n=41)
The SHMI for MI may be inaccurate due to the inclusion of type 2 MI or non-MI, and restricting the metric to type 1 MI provides a more accurate reflection of mortality and care quality.
May distort hospital MI mortality comparisons; leaves open whether type 1-only SHMI better reflects care quality.
BACKGROUND: The Summary Hospital-level Mortality Indicator (SHMI) for Myocardial Infarction (MI) is the ratio of the observed to the expected number of deaths due to MI. We aimed to assess (1) the accuracy of MI as a diagnosis in the SHMI for MI and (2) the healthcare received by patients with type 1 MI included in the SHMI for MI. METHODS: Retrospective review of patients included in SHMI for MI from April 2017 to March 2018. The diagnosis of MI was divided into type 1, type 2 and non-MI. For patients with type 1 MI who underwent intervention, we applied the prognostic Toronto Risk Score (TRS) and classified into group 0: score <13 (mortality risk 0%-4%, lowest risk), group 1: score 13-16 (mortality risk 6%-19.6%), group 2: score 17-19 (mortality risk 27.4%-47.6%) and group 3: score ≥20 (mortality risk 58%-92%). For patients with type 1 MI who underwent conservative management, we reviewed appropriateness of conservative management. RESULTS: SHMI for MI was 96 (41/42.83) falling to 65.4 with the inclusion of only type 1 MI (28 patients, 28/42.83). About 41.5% (n=17) underwent intervention of whom three were in the lowest risk TRS (group 0) and all received appropriate healthcare. Conservative management was appropriate for the 26.8% (n=11) treated medically, the most common reason was severe cognitive dysfunction. CONCLUSIONS: We have demonstrated that SHMI for MI can be inaccurate due to the inclusion of type 2 MI or non-MI. Grouping patients into intervention versus conservative management helps in assessment of healthcare.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2020) conducted an observational in Myocardial Infarction (n=41). Type 1 MI classification vs. Type 2 MI and non-MI was evaluated on Summary Hospital-level Mortality Indicator (SHMI) for MI. The Summary Hospital-level Mortality Indicator for MI fell from 96 to 65.4 when restricted to only type 1 MI, demonstrating that inclusion of type 2 or non-MI can cause inaccuracies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: